Goldman Sachs’s Esperion Therapeutics ESPR Stock Holding History

Goldman Sachs’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.6M	Sell	2,410,454 -437,762	-15%	-$1.39M	﹤0.01%	3434
2025 Q4	$10.5M	Buy	2,848,216 +1,139,409	+67%	+$3.68M	﹤0.01%	3045
2025 Q3	$4.53M	Buy	1,708,807 +910,053	+114%	+$1.76M	﹤0.01%	3735
2025 Q2	$786K	Sell	798,754 -728,532	-48%	-$729K	﹤0.01%	4867
2025 Q1	$2.2M	Sell	1,527,286 -1,225,974	-45%	-$2.26M	﹤0.01%	4081
2024 Q4	$6.06M	Buy	2,753,260 +1,445,592	+111%	+$3.37M	﹤0.01%	3260
2024 Q3	$2.16M	Buy	1,307,668 +391,657	+43%	+$791K	﹤0.01%	4094
2024 Q2	$2.03M	Sell	916,011 -2,448,255	-73%	-$5.76M	﹤0.01%	3902
2024 Q1	$9.02M	Buy	3,364,266 +2,306,865	+218%	+$5.61M	﹤0.01%	2560
2023 Q4	$3.16M	Sell	1,057,401 -119,595	-10%	-$155K	﹤0.01%	3563
2023 Q3	$1.15M	Buy	1,176,996 +351,285	+43%	+$508K	﹤0.01%	4174
2023 Q2	$1.15M	Buy	825,711 +124,550	+18%	+$174K	﹤0.01%	4258
2023 Q1	$1.11M	Sell	701,161 -27,177	-4%	-$140K	﹤0.01%	4309
2022 Q4	$4.54M	Buy	728,338 +262,539	+56%	+$1.88M	﹤0.01%	3260
2022 Q3	$3.12M	Buy	465,799 +204,241	+78%	+$1.4M	﹤0.01%	3569
2022 Q2	$1.66M	Sell	261,558 -107,953	-29%	-$612K	﹤0.01%	4201
2022 Q1	$1.72M	Buy	369,511 +82,242	+29%	+$353K	﹤0.01%	4379
2021 Q4	$1.44M	Buy	287,269 +259,716	+943%	+$2.08M	﹤0.01%	4534
2021 Q3	$332K	Sell	27,553 -10,931	-28%	-$159K	﹤0.01%	5434
2021 Q2	$814K	Buy	38,484 +20,766	+117%	+$500K	﹤0.01%	4907
2021 Q1	$497K	Sell	17,718 -80,495	-82%	-$2.37M	﹤0.01%	5128
2020 Q4	$2.55M	Buy	98,213 +52,744	+116%	+$1.58M	﹤0.01%	3538
2020 Q3	$1.69M	Sell	45,469 -266,692	-85%	-$10.6M	﹤0.01%	3691
2020 Q2	$16M	Buy	312,161 +75,275	+32%	+$3.15M	﹤0.01%	1860
2020 Q1	$7.47M	Sell	236,886 -168,925	-42%	-$8.91M	﹤0.01%	2316
2019 Q4	$24.2M	Buy	405,811 +114,392	+39%	+$5.14M	0.01%	1707
2019 Q3	$10.7M	Sell	291,419 -145,949	-33%	-$5.78M	﹤0.01%	2276
2019 Q2	$20.3M	Sell	437,368 -27,765	-6%	-$1.3M	0.01%	1841
2019 Q1	$18.7M	Buy	465,133 +135,796	+41%	+$6.09M	0.01%	1931
2018 Q4	$15.1M	Buy	329,337 +94,319	+40%	+$4.54M	﹤0.01%	2028
2018 Q3	$10.4M	Buy	235,018 +20,005	+9%	+$918K	﹤0.01%	2427
2018 Q2	$8.43M	Buy	215,013 +27,015	+14%	+$1.36M	﹤0.01%	2541
2018 Q1	$13.6M	Sell	187,998 -143,078	-43%	-$10.5M	﹤0.01%	2113
2017 Q4	$21.8M	Buy	331,076 +71,980	+28%	+$3.88M	0.01%	1878
2017 Q3	$13M	Buy	259,096 +9,485	+4%	+$457K	﹤0.01%	2336
2017 Q2	$11.6M	Buy	249,611 +187,728	+303%	+$6.9M	﹤0.01%	2391
2017 Q1	$2.19M	Buy	61,883 +19,654	+47%	+$450K	﹤0.01%	3660
2016 Q4	$529K	Sell	42,229 -7,493	-15%	-$89.2K	﹤0.01%	5014
2016 Q3	$689K	Buy	49,722 +1,710	+4%	+$19.4K	﹤0.01%	4746
2016 Q2	$474K	Buy	48,012 +7,000	+17%	+$116K	﹤0.01%	4890
2016 Q1	$694K	Sell	41,012 -1,019	-2%	-$16.4K	﹤0.01%	4416
2015 Q4	$936K	Buy	42,031 +21,991	+110%	+$555K	﹤0.01%	4362
2015 Q3	$473K	Buy	20,040 +8,553	+74%	+$537K	﹤0.01%	5198
2015 Q2	$939K	Sell	11,487 -4,668	-29%	-$457K	﹤0.01%	4586
2015 Q1	$1.5M	Buy	16,155 +10,479	+185%	+$676K	﹤0.01%	4065
2014 Q4	$230K	Buy	+5,676	New	+$174K	﹤0.01%	6043
2014 Q1	–	Sell	-11,819	Closed	-$162K	–	6806
2013 Q4	$162K	Sell	11,819 -4,933	-29%	-$71.8K	﹤0.01%	6069
2013 Q3	$316K	Buy	+16,752	New	+$281K	﹤0.01%	5530